Rania Abdullah Al Farsi

Gestational diabetes mellitus is considered as one of the most common medical complications of pregnancy as it has implications on both the mother and the child. It is caused by reduced pancreatic β-cells function as they don’t produce enough insulin to meet the requirements of pregnancy. Internationally, it is recommended to screen all pregnant women by measuring their glucose between 24 and 28 weeks of pregnancy. It can be managed either non-pharmacologically or pharmacologically depending on the severity of hyperglycemia. The present  study was intended to measure the prevalence of gestational diabetes mellitus in Oman and to explore the available treatment options in both governmental and private hospitals. Out of 1792 patients who attended the Gynecological department between the study period, a total of 219 patients visited gestational diabetes clinic at Sohar Hospital, Saham Polyclinic and a private hospital. Of the total number of participants from all the clinics, 103 had a family history of diabetes mellitus whereas 17 had no family history. 120 patients agreed to participate in questionnaire interview and were informed about the purpose of the study. A good response from patients is a good indication for a future national study.